Alimera to market lid scrub

Article

Alimera to market lid scrub

Alimera Sciences and CYNACON/OCuSOFT have signed and agreement for Alimera sales representatives to start detailing and sampling the OCuSOFT Lid Scrub family of eyelid cleansers to existing ophthalmic customers.

The eyelid cleansers are recommended for the removal of oil, debris and desquamated skin from the eyelids, in order to help manage conditions such as blepharitis and dry eye syndrome.

The lid scrub is available in pre-moistened pads, solution and lid scrub foam.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Related Content
A microphone in a stand is lit by a spotlight, shining on an empty stage. Image credit: ©Who is Danny – stock.adobe.com

See what our Editorial Advisory Board members are bringing to EURETINA

Hattie Hayes
September 12th 2024
Article

Spotlight on the retina specialists who make up the Eye Care Network advisory boards

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

The Earth with the EURETINA logo superimposed on top. Image credit: ©dimazel – stock.adobe.com and EURETINA

Celebrate World Retina Day at the 2024 EURETINA Congress

Hattie Hayes
September 10th 2024
Article

As part of the Barcelona meeting, retina specialists can recognise the awareness day early

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Ramin Tadayoni speaks at the 2023 EURETINA Congress. Image courtesy EURETINA.

Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award

Hattie Hayes
September 9th 2024
Article

The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field

A cell being injected by a syringe. Image credit: ©Corona Borealis – stock.adobe.com

Trinity team’s gene therapy offers promising glaucoma and AMD treatment

Martin David Harp
September 9th 2024
Article

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

© 2024 MJH Life Sciences

All rights reserved.